RecruitingNot ApplicableNCT05995886
Using Facebook to Support Opioid Recovery Among American Indian Women
Facebook Intervention for Preventing Opioid Relapse Among American Indian Women: Wiidookaage'Win Pilot Preparatory Study (Aim 2)
Sponsor
Mayo Clinic
Enrollment
60 participants
Start Date
Oct 16, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to find out whether a Facebook group will help Native women in recovery from opioid use.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria13
- AIAN person based on self-reported race/ethnicity
- Gender identity as a woman
- At least 18 years of age with no upper age limit
- Resides in Minnesota
- Meets criteria for OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013)
- Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen
- Current use of MOUD
- Is comfortable speaking and reading English
- Has an existing Facebook account or willing to set one up
- Is willing and able to participate in the Facebook intervention for 3 months
- Has access to broadband internet on a mobile phone/computer/tablet at any location
- Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS or is willing to and able to complete a virtual Zoom UDS visit.
- Provides written informed consent
Exclusion Criteria2
- Self-reports current suicidality based on the Concise Heath Risk Tracking scale
- Participated in prior study phases (Aim 1 formative work) of NIDA CTN-0123
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALWiidookaage'win Facebook Group
An online social media group program that incorporates social support, mindfulness-based, and cultural practices that may support OUD recovery.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05995886
Related Trials
Resilience Among Individuals With Opioid Use Disorder
NCT069544022 locations
Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment
NCT061042801 location
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
NCT067688141 location
Mobile Platform for Optimizing Wellness and Engagement in Recovery
NCT071789901 location
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
NCT063238246 locations